393 related articles for article (PubMed ID: 21546262)
1. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA and drug resistance.
Ma J; Dong C; Ji C
Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
5. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs.
Fojo T
Drug Resist Updat; 2007; 10(1-2):59-67. PubMed ID: 17350322
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
Kanakkanthara A; Miller JH
Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
[TBL] [Abstract][Full Text] [Related]
7. miRNAs modulate the drug response of tumor cells.
Wu X; Xiao H
Sci China C Life Sci; 2009 Sep; 52(9):797-801. PubMed ID: 19802736
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of microRNAs in resistance to lung cancer treatments.
MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
[TBL] [Abstract][Full Text] [Related]
9. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
Wei J; Xie L; Taron M; Rosell R; Liu B
Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and cancer resistance: A new molecular plot.
Fanini F; Fabbri M
Clin Pharmacol Ther; 2016 May; 99(5):485-93. PubMed ID: 26875151
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and cancer epigenetics: a macrorevolution.
Davalos V; Esteller M
Curr Opin Oncol; 2010 Jan; 22(1):35-45. PubMed ID: 19907325
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.
Husted S; Søkilde R; Rask L; Cirera S; Busk PK; Eriksen J; Litman T
Mol Pharm; 2011 Dec; 8(6):2055-62. PubMed ID: 21899346
[TBL] [Abstract][Full Text] [Related]
15. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNA in anticancer drug resistance.
Zheng T; Wang J; Chen X; Liu L
Int J Cancer; 2010 Jan; 126(1):2-10. PubMed ID: 19634138
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
Picker A; Jackson DB
Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as new therapeutic targets and tools in cancer.
Gandellini P; Profumo V; Folini M; Zaffaroni N
Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
